
Signogard 35mg Tablet MR
Marketer
Signova Pharma Pvt Ltd
Salt Composition
Trimetazidine (35mg)
Overview Signogard 35mg Tablet MR
Cardiogard 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest discomfort stemming from heart issues. This medication acts as a preventative measure against angina episodes; however, it's ineffective in halting an attack already in progress. It may be administered independently or alongside other cardiac medications, as determined by your physician. Consistent daily use, as directed, is crucial. Consumption with or without food is acceptable, maintaining a consistent schedule. Dosage frequency is subject to adjustment based on therapeutic response. Continuous use is vital for optimal effect, even during symptom-free periods, mitigating future cardiac events. Discontinuation may lead to a recurrence of angina. Lifestyle modifications such as smoking cessation, moderate alcohol consumption, balanced nutrition, regular physical activity, and stress management significantly contribute to cardiovascular well-being. Potential side effects include vertigo, cephalalgia, stomach upset, bowel irregularities, dyspepsia, nausea, emesis, dermatological reactions (rash, pruritus, urticaria), and asthenia. Report any persistent or bothersome adverse reactions to your doctor. Pre-existing liver or kidney conditions, pregnancy, breastfeeding, and concurrent medication use should be disclosed to your physician before commencing treatment to ensure suitability.
Primary Ingredients of Signogard 35mg Tablet MR
No information provided. Please provide the text you wish to be rewritten.
Uses of Signogard 35mg Tablet MR
Managing chest pain associated with angina pectoris
Major Benefits of Signogard 35mg Tablet MR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Signogard 35mg Modified-Release tablet should be taken with a meal.
Common Side effects of Signogard 35mg Tablet MR:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Signogard 35mg Tablet MR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not crush, chew, or fracture it. Signogard 35mg Modified-Release Tablets should be administered with a meal.
How Signogard 35mg Tablet MR works:
Signogard 35mg Modified-Release tablets are used to treat angina. They achieve this by altering the heart's energy source, favoring glucose over fatty acids, thereby reducing the heart's oxygen demand and improving its overall function.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Signogard 35mg Modified-Release tablets and alcohol may result in heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
Pregnancy-related data on the use of Signogard 35mg MR tablets is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Signogard 35mg MR Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Signogard 35mg Modified-Release tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Signogard 35mg Modified-Release Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Signogard 35mg Modified-Release Tablets are contraindicated in individuals with severe renal insufficiency.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Signogard 35mg modified-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Signogard 35mg Tablet MR :
Should you forget a Signogard 35mg MR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Signogard 35mg Tablet MR
| Label | Value |
|---|---|
| Chemical Category | Benzylamines |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Fatty acid and sodium channel modulator |
